Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : Bivalent Oral Polio Vaccine
Therapeutic Area : Infections and Infectious Diseases
Study Phase : Phase III
Sponsor : Serum Institute of India
Deal Size : Inapplicable
Deal Type : Inapplicable
A Clinical Study Comparing Safety and Immunogenicity of bOPV of Bilthoven Biologicals
Details : Bivalent Oral Polio Vaccine is a Vaccine drug candidate, which is currently being evaluated in phase III clinical studies for the treatment of Poliomyelitis.
Product Name : Undisclosed
Product Type : Vaccine
Upfront Cash : Inapplicable
May 10, 2016
Lead Product(s) : Bivalent Oral Polio Vaccine
Therapeutic Area : Infections and Infectious Diseases
Highest Development Status : Phase III
Sponsor : Serum Institute of India
Deal Size : Inapplicable
Deal Type : Inapplicable
Reset All
